- Undergraduate Education
- Hubei University of Chinese Medicine (Wuhan), China. MD, Medicine, 1992
- Graduate Education
- Tongji Medical University (Wuhan), China. Master of Medical Science, 1995
- Beijing Medical University, China. PhD in Medical Science, 1998
- Junior Faculty Award, American Diabetes Association, 2010
- Research Award, Minnesota Medical Foundation, 2004
- Travel Award, Dept. of BMBB, the University of Minnesota, 2001
- Pilot & Feasibility Research Award, Minnesota Obesity Center, 2002, 2005
- Travel Award, The Center for Diabetes Research, University of Minnesota, 2001
- Courses Taught
- NUTR 470: Nutrition and Physiological Chemistry
- NUTR 681: Nutrition Seminar
The long-term goal of Dr. Wu’s research program is to elucidate the mechanisms underlying the pathogenesis of obesity and overnutrition-associated metabolic diseases including insulin resistance, diabetes, and fatty liver disease so that novel dietary and/or pharmacological approaches can be developed for preventing and/or treating metabolic diseases. Using molecular, cellular, and integrative approaches, the Wu lab is focused on investigating the interaction between metabolism and inflammation.
Obesity, insulin resistance, diabetes, and fatty liver disease
- Kyritsi, K, Francis, H, Zhou, T, Ceci, L, Wu, N, Yhang, Z et al.. Downregulation of p16 decreases biliary damage and liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis. Gene Expr. 2020; :. doi: 10.3727/105221620X15889714507961. PubMed PMID:32393417 .
- Deng, M, Qu, F, Chen, L, Liu, C, Zhang, M, Ren, F et al.. SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD. J. Endocrinol. 2020;245 (3):425-437. doi: 10.1530/JOE-20-0018. PubMed PMID:32302970 .
- Ma, L, Li, H, Hu, J, Zheng, J, Zhou, J, Botchlett, R et al.. Indole Alleviates Diet-induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell PFKFB3. Hepatology. 2020; :. doi: 10.1002/hep.31115. PubMed PMID:31953865 .